Published in:
29-01-2024 | Gastrectomy | ASO Research Letter
Updated Analysis of a Phase 2 Trial of Cytoreduction, Gastrectomy, and Hyperthermic Intraperitoneal Perfusion with Chemotherapy for Patients with Peritoneal Carcinoma from Gastric Cancer
Authors:
Brian Badgwell, MD, MS, Jeannelyn Estrella, MD, Sinchita Roy-Chowdhuri, MD, PhD, Naruhiko Ikoma, MD, MS, Mariela Blum Murphy, MD, Jaffer Ajani, MD, Paul Mansfield, MD
Published in:
Annals of Surgical Oncology
|
Issue 5/2024
Login to get access
Excerpt
The current National Comprehensive Cancer Network (NCCN) guidelines recommend hyperthermic intraperitoneal chemotherapy (HIPEC) for carefully selected patients with stage IV gastric cancer in the setting of a clinical trial.
1 The purpose of this research report is to describe updated follow-up results from the first completed clinical trial of HIPEC for gastric cancer in the United States. …